Sab Biotherapeutics Inc Stock Performance
as on October 30, 2025 at 1:29 am IST
Day's Low
Day's High
$2.96$3.06
1.99%
Downside
1.32%
Upside
52 Week's Low
52 Week's High
$1$6.666.89%
Downside
118.54%
Upside
Sab Biotherapeutics Inc share price movements today
- Previous Close
- $3.02
- Open
- $2.97
- Volume
- 494.8K
- Day's Low - High
- $2.96 - $3.06
- 52 Week Low - High
- $1 - $6.6
Sab Biotherapeutics Inc Historical Returns
- 1 Month Return
- + 54.87 %
- 3 Month Return
- + 33.33 %
- 1 Year Return
- + 4.5 %
- 3 Year Return
- -65.15 %
- 5 Year Return
- 0 %
Sab Biotherapeutics Inc Stock Fundamentals & Key Indicators
Check Sab Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$31.5M
EPS (TTM)
-1.945
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.60%
PE Ratio (TTM)
-0.66
Industry PE ratio
0PEG Ratio
0EBITDA
-38.5M
Revenue (TTM)
114.7K
Profit Margin
0.00%
Return On Equity TTM
-127.48%
Sab Biotherapeutics Inc Stock Valuation
Track how Sab Biotherapeutics Inc P/E has moved over time to understand its valuation trends.
Sab Biotherapeutics Inc in the last 5 years
Lowest (-66.91x)
March 31, 2022
Industry (0.00x)
October 29, 2025
Today (-0.66x)
October 29, 2025
Highest (-0.44x)
June 30, 2025
Today’s Price to Earnings Ratio: -0.66x
Sab Biotherapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Sab Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $31.5M | NA | -0.66 | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
Stock Returns calculator for Sab Biotherapeutics Inc Stock including INR - Dollar returns
The Sab Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sab Biotherapeutics Inc investment value today
Current value as on today
₹1,09,560
Returns
₹9,560
(+9.56%)
Returns from Sab Biotherapeutics Inc Stock
₹4,498 (+4.5%)
Dollar Returns*
₹5,061 (+5.06%)
Analyst Recommendation on Sab Biotherapeutics Inc Stock
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Sab Biotherapeutics Inc. Average target price of $8.83
Sab Biotherapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Sab Biotherapeutics Inc.
What analysts predicted
65.8%UPSIDE
Target Price
$8.83
Current Price
$3.02
Analyzed by
8 Analysts
Target
$8.83
Sab Biotherapeutics Inc target price $8.83, a slight upside of 65.8% compared to current price of $3.02. According to 8 analysts rating.
Sab Biotherapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Sab Biotherapeutics Inc Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:25% versus previous 30 day period
Sab Biotherapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Sab Biotherapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Sab Biotherapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Sab Biotherapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Sab Biotherapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, SABS stock has moved up by 50.2%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.7% return, outperforming this stock by 197.9%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.1% return, outperforming this stock by 72.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -5.19M → -10.11M (in $), with an average decrease of 94.6% per quarter
About Sab Biotherapeutics Inc
| Organisation | Sab Biotherapeutics Inc |
| Headquarters | 777 W 41st St., Miami Beach, FL, United States, 33140 |
| CEO | Mr. Samuel J. Reich |
| E-voting on shares | Click here to vote |
Key Management of Sab Biotherapeutics Inc
Name | Title |
|---|---|
Ms. Lucy To | Executive VP & CFO |
Ms. Catherine DeRose | Vice President of Human Resources |
Ms. Angie Parizek | Senior Vice President of Clinical Operations |
Mr. Samuel J. Reich | Chairman & CEO |
Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director |
Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO |
Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer |
Ms. Hua Wu Ph.D. | Senior Vice President of Product Development |
Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs |
FAQs
What is Sab Biotherapeutics Inc share price today?
Sab Biotherapeutics Inc share price today is $3.02 as on at the close of the market. Sab Biotherapeutics Inc share today touched a day high of $3.06 and a low of $2.96.
What is the 52 week high and 52 week low for Sab Biotherapeutics Inc share?
Sab Biotherapeutics Inc share touched a 52 week high of $6.6 on and a 52 week low of $1 on . Sab Biotherapeutics Inc stock price today i.e. is closed at $3.02,which is 54.24% down from its 52 week high and 202.00% up from its 52 week low.
What is Sab Biotherapeutics Inc's market capitalisation today?
Sab Biotherapeutics Inc market capitalisation is $0.00T as on .
How to invest in Sab Biotherapeutics Inc Stock (SABS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Sab Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sab Biotherapeutics Inc Shares that will get you 0.4967 shares as per Sab Biotherapeutics Inc share price of $3.02 per share as on October 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Sab Biotherapeutics Inc Stock (SABS) from India?
Indian investors can start investing in Sab Biotherapeutics Inc (SABS) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Sab Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sab Biotherapeutics Inc share’s latest price of $3.02 as on October 30, 2025 at 1:29 am IST, you will get 3.3113 shares of Sab Biotherapeutics Inc. Learn more about
fractional shares .